×
Hero Background

Overactive Bladder Treatment Companies

ID: MRFR/HC/4787-HCR
200 Pages
Rahul Gotadki
October 2025

Overactive bladder (OAB) is a medical condition characterized by a sudden, involuntary contraction of the muscles in the bladder wall, leading to a frequent and urgent need to urinate. Several pharmaceutical and biotechnology companies focus on the development of treatments for OAB.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Overactive Bladder Treatment Market Research Report – Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Overactive Bladder Treatment Market

Overactive Bladder Treatment Market

 


Latest Overactive Bladder Treatment Companies Updates:


Astellas Pharma expands indications for Myrbetriq® (mirabegron) to include treatment of overactive bladder (OAB) with urge urinary incontinence (UUI) in men in the US: This approval broadens the reach of this popular medication, benefiting more OAB patients.


Medtronic unveils a new neuromodulation therapy system for OAB, the InterStim™ Micro neurostimulator: This smaller, implantable device offers a less invasive option for patients seeking long-term relief from OAB symptoms.


Urovant Sciences receives FDA approval for Géneresse® (vibegron extended-release tablets) for the treatment of OAB in adults: This new generic drug expands treatment options and potentially contributes to cost reduction for patients.


Botox® continues to dominate the neuromodulation segment: Allergan's botulinum toxin A injections remain a well-established option for OAB treatment, despite increasing competition from newer technologies.


List of Overactive Bladder Treatment Key companies in the market:



  • Astellas Pharma Inc.

  • Pfizer Inc.

  • Teva Pharmaceutical

  • Allergan Plc.

  • Mylan N.V.

  • Endo International Plc

  • Hisamitsu Pharmaceutical Co. Inc.

  • Sanofi S. A.

  • Aurobindo Pharma Limited

  • Johnson & Johnson"